Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
Authors
Keywords
Kidneys, Fibrosis, Transcription factors, Vitamin D, Image analysis, Renin-angiotensin system, MAPK signaling cascades, Quantitative analysis
Journal
PLoS One
Volume 12, Issue 7, Pages e0181757
Publisher
Public Library of Science (PLoS)
Online
2017-07-29
DOI
10.1371/journal.pone.0181757
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structured DAG oil ameliorates renal injury in streptozotocin-induced diabetic rats through inhibition of NF-κB and activation of Nrf2 pathway
- (2017) Kankana Das et al. FOOD AND CHEMICAL TOXICOLOGY
- Commentary for “human kidney pericytes produce renin”
- (2016) Armin Kurtz KIDNEY INTERNATIONAL
- Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats
- (2016) Amal M. Mahfoz et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model
- (2016) Gulay Bulut et al. RENAL FAILURE
- Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice
- (2016) Sarah Chung et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Physiology of the Renal Interstitium
- (2015) M. Zeisberg et al. Clinical Journal of the American Society of Nephrology
- Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2
- (2015) Soojeong Kim et al. International Journal of Medical Sciences
- Novel RAAS agonists and antagonists: clinical applications and controversies
- (2015) Cesar A. Romero et al. Nature Reviews Endocrinology
- Understanding the mechanisms of kidney fibrosis
- (2015) Dong Zhou et al. Nature Reviews Nephrology
- Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study
- (2014) Marcin Renke et al. Advances in Medical Sciences
- Indoxyl Sulfate-Induced Activation of (Pro)Renin Receptor Is Involved in Expression of TGF-β1 and α-Smooth Muscle Actin in Proximal Tubular Cells
- (2014) Shinichi Saito et al. ENDOCRINOLOGY
- Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling
- (2014) Yu Hong et al. Journal of Translational Medicine
- Effects of Paricalcitol and Aliskiren Combination Therapy on Experimental Diabetic Nephropathy Model in Rats
- (2014) Zehra Eren et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2
- (2014) Sungjin Chung et al. Nutrition & Metabolism
- Renin Inhibition Reverses Renal Disease in Transgenic Mice by Shifting the Balance Between Profibrotic and Antifibrotic Agents
- (2013) Panagiotis Kavvadas et al. HYPERTENSION
- Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways
- (2013) Xiao-hua Ning et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Synergistic Effect of Mizoribine and a Direct Renin Inhibitor, Aliskiren, on Unilateral Ureteral Obstruction Induced Renal Fibrosis in Rats
- (2013) Koji Sakuraya et al. JOURNAL OF UROLOGY
- Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model
- (2012) E Ari et al. BRITISH JOURNAL OF RADIOLOGY
- Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury
- (2012) Azhar Rashikh et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Protective Effect of Paricalcitol on Cyclosporine-Induced Renal Injury in Rats
- (2012) S.G. Piao et al. TRANSPLANTATION PROCEEDINGS
- Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
- (2011) M. H. de Borst et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aliskiren Ameliorates Renal Inflammation and Fibrosis Induced by Unilateral Ureteral Obstruction in Mice
- (2011) Dae Eun Choi et al. JOURNAL OF UROLOGY
- Investigating mechanisms of chronic kidney disease in mouse models
- (2011) Allison A. Eddy et al. PEDIATRIC NEPHROLOGY
- Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice
- (2010) Yi-Fei Dong et al. JOURNAL OF HYPERTENSION
- Mechanisms of Tubulointerstitial Fibrosis
- (2010) M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy
- (2009) Xiaoyue Tan et al. KIDNEY INTERNATIONAL
- Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling
- (2008) X. Tan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now